Advanced search
Log in
Forgot password ?
Remember
Or log in with
Google
Twitter
Facebook
Apple
Sign up
Email Registration
Or log in with
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Français (Suisse)
Italiano
Nederlands (Nederland)
Nederlands (België)
Markets
Equities
Top Capitalization
United States
North America
Europe
Asia
Middle East
Sector Research
Financial Calendar
Equities Analysis
Most popular
ALPHABET INC.
MICROSOFT CORPORATION
META PLATFORMS, INC.
APPLE INC.
AMAZON.COM, INC.
TESLA, INC.
NVIDIA CORPORATION
Indexes
Homepage
Rankings
Europe
America
Asia
Africa
Index Analysis
Indexes News
S&P 500
DOW JONES
NASDAQ 100
TSX COMP
FTSE 100
DAX
CAC 40
EURO STOXX 50
Currency / Forex
Homepage
Rankings
Currency Cross Rate
Currency Converter
Forex Analysis
Currencies News
USD / EUR
USD / CAD
USD / MXN
USD / BRL
USD / INR
Commodities
Homepage
Energy
Precious metals
Agriculture
Industrial Metals
Livestock and Cattle
GOLD
CRUDE OIL (WTI)
CRUDE OIL (BRENT)
SILVER
PLATINUM
Cryptocurrencies
Homepage
Rankings
Charts
Analysis
News
BITCOIN
ETHEREUM
BINANCE COIN
SOLANA
CARDANO
FTX TOKEN
Interest Rates
Homepage
Developed Nations
Emerging Countries
ETFs Rates
ETF
Rankings and News
Advanced Search
News
All News
World
United States
Europe
North America
South America
Asia
Africa
Middle East
Emerging
Companies
All News
Analyst Reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit Warnings
Appointments
Press Releases
Security Transactions
Earnings reports
New markets
New products
Corporate strategies
Legal risks
Share buybacks
Mergers and acquisitions
Call Transcripts
Guidance
Indexes
Currency / Forex
Commodities
Cryptocurrencies
ETF
Interest Rates
Economy
Themes
Asset Management
Activism
Climate and ESG
Cybersecurity
Geopolitics
Central Banks
Private Equity
Inflation
Business Leaders
Sectors
All our articles
Most Read News
Hot News
Analysis
All Analysis
Must Read
Equities
Indexes
Currencies
Commodities
Cryptocurrencies
Stock Trading Strategies
All
America
Europe
Asia
Our Shows
Shows
World Press Review
Pump & Dump
Must Watch
Satirical Cartoon
Today's Editorial
Crypto Recap
Stock Picks
Portfolios
Virtual Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Watchlists
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment Style
Homepage
Trend-Following Stocks
Momentum stocks
Undervalued stocks
Quality stocks
Yield stocks
ESG stocks
Investment Themes
Homepage
Sin stocks
Education
Robotics
The Golden Age of Video Games
In Vino Veritas
Boats
Rankings
Top Movers
Top Movers
Unusual volumes
New Historical Highs
New Historical Lows
Long Term
Top Fundamentals
Top Fundamentals
Sales growth
Earnings Growth
Profitability
Finances
Rankings Valuation
Rankings Valuation
P/E ratio
Enterprise value
Yield
Top Consensus
Top Consensus
Analyst Opinion
Target price
Estimates Revisions
Divergence
Top Technicals
Top RSI
Unusual volumes
GAPS
STIM
Breakouts
Trends
Volatility
Top ranking ESG
Top ranking ESG
Environnement
Social
Gouvernance
Rankings Coverage
Screeners
Stock Screener Home
Investment Themes
The Cannabis Industry
Robotics
Financial Data
The Golden Age of Video Games
In Vino Veritas
Cybersecurity
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Low valuations
My Screeners
All my stocks
Watchlists
Virtual Portfolios
Tools
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Dynamic Chart
Financial Calendar
Economic Calendar
Currency Converter
ProRealTime Trading
Our Services
Our subscriptions
Our Stock Picks
Stock Screener
Thematic Investment Lists
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Homepage
Equities
United Kingdom
London Stock Exchange
GSK plc
News
Summary
GSK
GB00BN7SWP63
GSK PLC
(GSK)
Add to my list
Report
Real-time Estimate Cboe Europe -
11:30:00 2023-02-03 am EST
1435.70
GBX
+0.58%
02:44a
Gsk: morgan stanley cuts target price to 1485p from 1520p…
RE
02/02
GSK plc - Benlysta granted Orphan Drug Designation by US FDA for the potential treatment of systemic sclerosis
AQ
02/02
GSK : Credit Suisse gives a Neutral rating
MD
Summary
Quotes
Charts
News
Ratings
Calendar
Company
Financials
Consensus
Revisions
Funds
Summary
Most relevant
All News
Analyst Reco.
Other languages
Press Releases
Official Publications
Sector news
MarketScreener Strategies
GSK Names Burberry Executive Julie Brown New Finance Chief
09/26/2022 | 04:47am EST
Send by mail :
Name :
First name :
From
*
:
To
*
:
(You can enter multiple email addresses separated by commas)
Message :
*
Required fields
© MT Newswires 2022
Stocks mentioned in the article
Change
Last
1st jan.
ASTRAZENECA PLC
2.85%
10542
-8.63%
BURBERRY GROUP PLC
0.04%
2471
21.67%
GSK PLC
0.99%
1441.2
-0.71%
SMITH & NEPHEW PLC
3.40%
1187
3.61%
All news about GSK PLC
02:44a
Gsk: morgan stanley cuts target price to 1485p from 1520p…
RE
02/02
GSK plc - Benlysta granted Orphan Drug Designation by US FDA for the potential treatmen..
AQ
02/02
GSK : Credit Suisse gives a Neutral rating
MD
02/02
GSK : Deutsche Bank reiterates its Neutral rating
MD
02/02
JPMorgan Keeps GSK at Underweight, Raises PT
MT
02/02
GSK : Sell rating from JP Morgan
MD
02/02
Gsk : FY 2022 results transcript
PU
02/02
Jesduvroq (daprodustat) approved by US FDA for anaemia of chronic kidney disease in ad..
AQ
02/02
Benlysta granted Orphan Drug Designation by US FDA for the potential treatment of syste..
AQ
02/02
GSK gets FDA approval for drug to treat anaemia in adults on dialysis
AN
More news
Analyst Recommendations on GSK PLC
02:44a
Gsk: morgan stanley cuts target price to 1485p from 1520p…
RE
02/02
GSK : Credit Suisse gives a Neutral rating
MD
02/02
GSK : Deutsche Bank reiterates its Neutral rating
MD
More recommendations
Financials
GBP
USD
Sales 2022
29 105 M
35 719 M
35 719 M
Net income 2022
6 339 M
7 780 M
7 780 M
Net Debt 2022
14 349 M
17 609 M
17 609 M
P/E ratio 2022
8,60x
Yield 2022
4,27%
Capitalization
57 597 M
70 685 M
70 685 M
EV / Sales 2022
2,47x
EV / Sales 2023
2,47x
Nbr of Employees
90 096
Free-Float
93,7%
More Financials
Chart GSK PLC
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Full-screen chart
Technical analysis trends GSK PLC
Short Term
Mid-Term
Long Term
Trends
Neutral
Neutral
Bearish
Technical analysis
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
More Financials
Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
1 427,40 GBX
Average target price
1 697,73 GBX
Spread / Average Target
18,9%
Consensus
EPS Revisions
Please enable JavaScript in your browser's settings to use dynamic charts.
More Estimates Revisions
Managers and Directors
Emma N. Walmsley
Chief Executive Officer & Executive Director
Iain James Mackay
Chief Financial Officer & Executive Director
Jonathan Richard Symonds
Non-Executive Chairman
Jon Ellis
VP & Head-Technology Business Development
Tony Wood
Chief Scientific Officer
More about the company
Sector and Competitors
1st jan.
Capi. (M$)
GSK PLC
-0.71%
70 685
JOHNSON & JOHNSON
-6.29%
432 802
ELI LILLY AND COMPANY
-6.36%
314 224
NOVO NORDISK A/S
-3.40%
300 394
ROCHE HOLDING AG
-5.73%
264 917
MERCK & CO., INC.
-6.75%
262 312
More Results
Master